BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24615339)

  • 1. REDD1/DDIT4-independent mTORC1 inhibition and apoptosis by glucocorticoids in thymocytes.
    Wolff NC; McKay RM; Brugarolas J
    Mol Cancer Res; 2014 Jun; 12(6):867-77. PubMed ID: 24615339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition.
    Lesovaya EA; Savinkova AV; Morozova OV; Lylova ES; Zhidkova EM; Kulikov EP; Kirsanov KI; Klopot A; Baida G; Yakubovskaya MG; Gordon LI; Readhead B; Dudley JT; Budunova I
    Mol Cancer Ther; 2020 Sep; 19(9):1898-1908. PubMed ID: 32546661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REDD1 is essential for stress-induced synaptic loss and depressive behavior.
    Ota KT; Liu RJ; Voleti B; Maldonado-Aviles JG; Duric V; Iwata M; Dutheil S; Duman C; Boikess S; Lewis DA; Stockmeier CA; DiLeone RJ; Rex C; Aghajanian GK; Duman RS
    Nat Med; 2014 May; 20(5):531-5. PubMed ID: 24728411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabetics.
    Williamson DL; Dungan CM; Mahmoud AM; Mey JT; Blackburn BK; Haus JM
    Am J Physiol Regul Integr Comp Physiol; 2015 Oct; 309(8):R855-63. PubMed ID: 26269521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REDD1 (regulated in development and DNA damage 1) modulates the glucocorticoid receptor function in keratinocytes.
    Chudakova DA; Trubetskoy D; Baida G; Bhalla P; Readhead B; Budunova I
    Exp Dermatol; 2023 Oct; 32(10):1725-1733. PubMed ID: 37483165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade.
    Kumari R; Willing LB; Jefferson LS; Simpson IA; Kimball SR
    Biochem Biophys Res Commun; 2011 Sep; 412(4):644-7. PubMed ID: 21856283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy.
    Miller WP; Sunilkumar S; Dennis MD
    Free Radic Biol Med; 2021 Mar; 165():127-136. PubMed ID: 33524531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Glucocorticoid Elevation and Associated Fetal Thymocyte Apoptosis are Involved in Immune Disorders of Prenatal Caffeine Exposed Offspring Mice.
    Liu HX; Chen T; Wen X; Qu W; Liu S; Yan HY; Hou LF; Ping J
    Sci Rep; 2017 Oct; 7(1):13746. PubMed ID: 29062003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia.
    Miao ZF; Sun JX; Adkins-Threats M; Pang MJ; Zhao JH; Wang X; Tang KW; Wang ZN; Mills JC
    Gastroenterology; 2021 Jan; 160(1):260-271.e10. PubMed ID: 32956680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms driving fasting-induced protection from genotoxic injury in the small intestine.
    Deans-Fielder K; Wu T; Nguyen T; To S; Huang YZ; Bark SJ; Mills JC; Shroyer NF
    Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G504-G524. PubMed ID: 38349111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation.
    Zimmerman JAO; Fang M; Pufall MA
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection.
    Pourhassan H; Murphy L; Aldoss I
    Curr Hematol Malig Rep; 2024 Jun; ():. PubMed ID: 38867099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to "Articular Cartilage Regeneration via Induced Chondrocyte Autophagy by Sustained Release of Leptin Inhibitor from Thermo-Sensitive Hydrogel Through STAT3/REDD1/mTORC1 Cascade".
    Huang Z; Liu C; Zheng G; Zhang L; Zhong Q; Zhang Y; Zhao W; Qi Y
    Adv Healthc Mater; 2024 Mar; 13(7):e2304470. PubMed ID: 38279600
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing glucocorticoid toxicity: are the measures sensitive enough?
    Robson JC; Dawson J; Ndosi M
    Lancet Rheumatol; 2023 Mar; 5(3):e113-e114. PubMed ID: 38251606
    [No Abstract]   [Full Text] [Related]  

  • 15. A new posttranslational regulation of REDD1/DDIT4 through cleavage by caspase 3 modifies its cellular function.
    Puissant A; Fenouille N; Robert G; Jacquel A; Bassil CF; Colosetti P; Luciano F; Auberger P
    Cell Death Dis; 2014 Jul; 5(7):e1349. PubMed ID: 25058423
    [No Abstract]   [Full Text] [Related]  

  • 16. REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids.
    Baida G; Bhalla P; Kirsanov K; Lesovaya E; Yakubovskaya M; Yuen K; Guo S; Lavker RM; Readhead B; Dudley JT; Budunova I
    EMBO Mol Med; 2015 Jan; 7(1):42-58. PubMed ID: 25504525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.
    Dennis MD; Coleman CS; Berg A; Jefferson LS; Kimball SR
    Sci Signal; 2014 Jul; 7(335):ra68. PubMed ID: 25056877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient-induced stimulation of protein synthesis in mouse skeletal muscle is limited by the mTORC1 repressor REDD1.
    Gordon BS; Williamson DL; Lang CH; Jefferson LS; Kimball SR
    J Nutr; 2015 Apr; 145(4):708-13. PubMed ID: 25716553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing.
    Pavía-Jiménez A; Tcheuyap VT; Brugarolas J
    Nat Protoc; 2014 Aug; 9(8):1848-59. PubMed ID: 25010905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes and expressions of Redd1 in neurons and glial cells in the gerbil hippocampus proper following transient global cerebral ischemia.
    Lee CH; Park JH; Cho JH; Ahn JH; Yan BC; Lee JC; Shin MC; Cheon SH; Cho YS; Cho JH; Kwon YG; Lee DK; Kim YM; Won MH
    J Neurol Sci; 2014 Sep; 344(1-2):43-50. PubMed ID: 24980938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.